Rheumatology Advisor
The Grand Roundup: Pediatric Rheumatology. The Grand Roundup: Rheumatoid Arthritis. The Grand Roundup: Systemic Lupus Erythematosus. Rheumtaology Advisor offers featured news, research updates, and treatment guidelines to Rheumatology healthcare professionals.
2022 ACR/AAHKS Guidelines for Management of
Apr 6, 2022 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty: guideline summary.
American College of Rheumatology Releases Updated Guidelines …
Jun 18, 2021 · The American College of Rheumatology (ACR) recently released updated guidelines for the pharmacologic management of rheumatoid arthritis (RA). The full report has been published simultaneously in Arthritis Care & Research and Arthritis & Rheumatology.. Overall, the updated guidelines include treatment with disease-modifying antirheumatic drugs (DMARDs), including biologic DMARDs (bDMARDs) and ...
2022 ACR Guideline Update for the Prevention and Treatment of ...
Dec 8, 2023 · The updated guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis covered the period from April 23, 2016, to January 24, 2022. The American College of Rheumatology released updated guidelines for the prevention and treatment of GIOP.
Overview of Latest Treatment Strategies for Active Psoriatic …
An abstract presented at ACR 2023 reported on the results of the interleukin (IL)-17 inhibitor bimekizumab among patients with active PsA from the BE OPTIMAL (ClinicalTrials.gov identifier: NCT03895203) and BE COMPLETE trials (ClinicalTrials.gov identifier: NCT03896581). 1 Using these data, what is the effect of bimekizumab vs placebo on patient-reported outcomes, including pain and fatigue ...
Belimumab Enhances SLE Treatment Outcomes - Rheumatology …
1 day ago · Belimumab demonstrates notable efficacy for enhancing treatment outcomes among adults with active systemic lupus erythematosus (SLE) when added to standard therapy, according to study results published in The Lancet Rheumatology.. In a post-hoc analysis of pooled data from 5 phase 3 trials (ClinicalTrials.gov Identifiers: NCT00410384, NCT00424476, NCT01345253, NCT01484496, NCT01632241 ...
What Rheumatologists Need to Know About Cancer Risk in …
Apr 30, 2021 · In the United States, the lifetime risk of developing cancer is 1 in 3 individuals. 1 For patients with rheumatoid arthritis (RA), this risk may be increased due to the shared etiology between cancer and RA and the immunomodulatory nature of agents commonly used in RA treatment. 2 When determining appropriate therapeutic options for patients with RA and cancer, providers must make complex ...
Interleukin-6 Receptor Inhibitors for the Treatment of Rheumatoid ...
Although the 2020 American College of Rheumatology guidelines for the management of RA are pending publication, the European League Against Rheumatism (EULAR) recently released updated recommendations for the management of RA with synthetic and biological DMARDs. 8 There is a consensus that csDMARDs are the mainstay of RA treatment, and the 2019 update of the EULAR recommendations supported ...
Updated EULAR Recommendations for Rheumatoid Arthritis …
Feb 13, 2020 · Based on emerging new evidence and expert consensus, an international task force put together by the European League Against Rheumatism (EULAR) released updated recommendations for the management of rheumatoid arthritis (RA) with synthetic and biologic disease-modifying antirheumatic drugs (DMARDs). This report was published in Annals of the ...
Updated Treatment Recommendations for Psoriatic Arthritis
Aug 19, 2022 · The updated GRAPPA recommendations are intended for all clinicians who care for patients with PsA. The GRAPPA recommendations use a domain-based approach, which spans the 6 domains of PsA, which include peripheral arthritis, axial disease, enthesitis, dactylitis, skin psoriasis, and nail psoriasis. The recommendations also include important ...